Results you can bank on.

 

Tissue and eye banks achieve a relative discard reduction of 40%.

 

TP/HIV test now CE Marked.

One Test. More Answers. Test for multiple diseases at the same time.

Helping people know

Our patented Rapid Vertical Flow Technology delivers fast, accurate results

Rapid testing reinvented

Our patented Rapid Vertical Flow Technology delivers fast, accurate results.

Test. Results. Before the patient leaves.

Instant HIV results using whole blood, serum or plasma.

Our Products in Action

Reveal Single Tests

FDA-approved, MedMira’s Reveal G4 provides instant HIV results.

Learn More >

Multiplo Multiplex Tests

MedMira’s Multiplo multiplex tests include combination testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis.

Learn More >

Miriad Research Tools

Miriad includes toolkits to develop new diagnostic tests and commercialized combination tests.

Learn More >

About MedMira

MedMira is dedicated to improving human health by providing the best in rapid diagnostics. Our patented Rapid Vertical Flow Technology™ delivers fast, accurate results for a range of applications—helping care providers and their patients know more, instantly.

MedMira News >

MedMira Reports First Quarter Results

Halifax, Nova Scotia, December 22, 2017 – MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2017.

 

MedMira Reports 2017 Fourth Quarter and Year End Financial Results

Halifax, Nova Scotia, March 31, 2017 – MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter and year ended July 31, 2017.

 

MedMira Reports FY2017 Third Quarter Results

Halifax, Nova Scotia, June 29, 2017 – MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the three and nine month periods ending April 30, 2017.

 

©2018 MedMira Inc. All Rights Reserved.

Follow us on